Gemin X Pharmaceuticals Inc — Form D
Gemin X Pharmaceuticals Inc of Montreal, A8, a company, filed a Form D exempt-offering notice with the SEC on 2010-05-14. The offering totals $8.5M, of which $3.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-05-14
- Form: D
- Accession: 0001407168-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $8.5M
- Amount sold: $3.9M
- Remaining: $4.6M
- Investors: 16
- Date of first sale: 2010-05-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-142104
Issuer
- Name: Gemin X Pharmaceuticals Inc
- CIK: 0001407168
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 3576 AVENUE DU PARC, Montreal, A8, H2X 2H7
- Phone: 514-281-8989
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Timothy J Barberich | Director | Woburn, MA |
| Peter R Dolan | Director | Malvern, PA |
| Robert J Gorman | Director | Malvern, PA |
| ANDREW R JORDAN | Director | LEWISVILLE, TX |
| Robert G McNeil | Director | La Jolla, CA |
| Scott J Morenstein | Director | Malvern, PA |
| Eric W Roberts | Director | La Jolla, CA |
| Gordon C Shore | Director | Montreal, A8 |
| D. Michael Dixon | Executive Officer | Montreal, A8 |
| Peter R Dolan | Executive Officer | Malvern, PA |
| Gordon C Shore | Executive Officer | Montreal, A8 |
| Jean Michael Viallet | Executive Officer | Malvern, PA |
| Robert Gorman | Director | NORTHBROOK, IL |
| Aaron Davidson | Director | Toronto, A6 |
| Jean Viallet | Executive Officer | Montreal, A8 |
Other filings by this issuer (1)
More